EUVIMEDOpdag EUVIMED
Crossref

Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent

Bing Shang, Yaqiong Dong, Bo Feng, Jingyan Zhao, Zhi Wang, Debbie C Crans, Xiaoda Yang

British Journal of Pharmacology · 2024-11 · 181 (21) · 4214-4228

DOI: 10.1111/bph.16485 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2024-07-04. Written by Bing Shang and 6 co-authors. Institution: State Key Laboratory of Natural and Biomimetic Drugs and Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University Health …. Major MEDLINE topics: Hypoglycemic Agents, Estradiol, Diabetes Mellitus, Type 2, Diabetes Mellitus, Experimental. Cited 13 times so far (Crossref); 53 references. Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Metal‐based therapeutic agents are limited by the required concentration of metal‐based agents. Hereby, we determined if combination with 17β‐oestradiol (E2) could reduce such levels and the therapy still be effective in type 2 diabetes mellitus (T2DM). Experimental Approach The metal‐based agent (vanadyl acetylacetonate [VAC])– 17β‐oestradiol (E2) combination is administered using the membrane‐permeable graphene quantum dots (GQD), the vehicle, to form the active GQD–E2–VAC complexes, which was characterized by fluorescence spectra, infrared spectra and X‐ray photoelectron spectroscopy. In db / db type 2 diabetic mice, the anti‐diabetic effects of GQD–E2–VAC complexes were evaluated using blood glucose levels, oral glucose tolerance test (OGTT), serum insulin levels, homeostasis model assessment (homeostasis model assessment of insulin resistance [HOMA‐IR] and homeostasis model assessment of β‐cell function [HOMA‐β]), histochemical assays and western blot. Key Results In diabetic mice, GQD–E2–VAC complex had comprehensive anti‐diabetic effects, including control of hyperglycaemia, improved insulin sensitivity, correction of hyperinsulinaemia and prevention of β‐cell loss. Co‐regulation of thioredoxin interacting protein (TXNIP) activation by the combination of metal complex and 17β‐oestradiol contributed to the enhanced anti‐diabetic effects. Furthermore, a potent mitochondrial protective antioxidant, coniferaldehyde, significantly potentiates the protective effects of GQD–E2–VAC complexes. Conclusion and Implications A metal complex–E2 combinatorial approach achieved simultaneously the protection of β cells and insulin enhancement at an unprecedented low dose, similar to the daily intake of dietary metals in vitamin supplements. This study demonstrates the positive effects of combination and multi‐modal therapies towards type 2 diabetes treatment.

Subjects

MeSH terms (MEDLINE)

Hypoglycemic AgentsEstradiolDiabetes Mellitus, Type 2Diabetes Mellitus, ExperimentalAnimalsMiceMaleQuantum DotsDrug Therapy, CombinationMice, Inbred C57BLGraphiteVanadium CompoundsBlood GlucosePentanonesInsulin

Author keywords

17β‐oestradioldiabetes mellitusgraphene quantum dotspancreatic β‐cellvanadium

Substances

Hypoglycemic AgentsEstradiolGraphiteVanadium CompoundsBlood GlucosePentanonesInsulin

Authors and institutions

  • State Key Laboratory of Natural and Biomimetic Drugs and Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
  • Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, China.
  • Department of Chemistry and Cell and Molecular Biology Program, College of Natural Science, Colorado State University, Fort Collins, Colorado, USA.
  • SATCM Key Laboratory of Compound Drug Detoxification, Peking University Health Science Center, Beijing, China.

Funding

  • National Natural Science Foundation of China

Cite

APA

Shang, B., Dong, Y., Feng, B., Zhao, J., Wang, Z., Crans, D. C., & Yang, X. (2024). Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent. British Journal of Pharmacology, 181(21), 4214-4228. https://doi.org/10.1111/bph.16485

Vancouver

Shang B, Dong Y, Feng B, Zhao J, Wang Z, Crans DC, et al. Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent. British Journal of Pharmacology. 2024;181(21):4214-4228. doi:10.1111/bph.16485

BibTeX
@article{Shang2024,
  author = {Shang, Bing and Dong, Yaqiong and Feng, Bo and Zhao, Jingyan and Wang, Zhi and Crans, Debbie C and Yang, Xiaoda},
  title = {Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent},
  journal = {British Journal of Pharmacology},
  year = {2024},
  volume = {181},
  number = {21},
  pages = {4214--4228},
  doi = {10.1111/bph.16485}
}
Start for free →